These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Late effects of chronic graft-vs.-host disease in minor salivary glands. Alborghetti MR; Corrêa ME; Adam RL; Metze K; Coracin FL; de Souza CA; Cintra ML J Oral Pathol Med; 2005 Sep; 34(8):486-93. PubMed ID: 16091116 [TBL] [Abstract][Full Text] [Related]
8. Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis. Owsianowski M; Gollnick H; Siegert W; Schwerdtfeger R; Orfanos CE Bone Marrow Transplant; 1994 Nov; 14(5):845-8. PubMed ID: 7889018 [TBL] [Abstract][Full Text] [Related]
9. Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation. Michallet M; Perrin MC; Belhabri A; Molina L; Nicolini F; Tigaud JD; Sotto JJ; Guyotat D; Fière D; Archimbaud E Bone Marrow Transplant; 1999 Jan; 23(2):145-50. PubMed ID: 10197799 [TBL] [Abstract][Full Text] [Related]
10. Severe oral manifestations of chronic graft-vs.-host disease. França CM; Domingues-Martins M; Volpe A; Pallotta Filho RS; Soares de Araújo N J Am Dent Assoc; 2001 Aug; 132(8):1124-7. PubMed ID: 11575020 [TBL] [Abstract][Full Text] [Related]
11. [A case of chronic graft-versus-host disease presenting with polymyositis]. Okazaki T; Maeda A; Inoue M; Kitazono T; Shibata T; Ozaki S Nihon Rinsho Meneki Gakkai Kaishi; 2009 Apr; 32(2):124-8. PubMed ID: 19404011 [TBL] [Abstract][Full Text] [Related]
12. Do corticosteroids add any benefit to standard GVHD prophylaxis in allogeneic BMT? Ancín I; Ferrá C; Gallardo D; Peris J; Berlanga J; Gonzalez JR; Virgili N; Grañena A Bone Marrow Transplant; 2001 Jul; 28(1):39-45. PubMed ID: 11498742 [TBL] [Abstract][Full Text] [Related]
13. FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and/or other immunosuppressants. Japanese FK506 BMT Study Group. Kanamaru A; Takemoto Y; Kakishita E; Dohy H; Kodera Y; Moriyama Y; Shibata A; Kasai M; Katoh S; Saitoh H Bone Marrow Transplant; 1995 Jun; 15(6):885-9. PubMed ID: 7581086 [TBL] [Abstract][Full Text] [Related]
14. Treatment of steroid-resistant graft-versus-host disease after allogeneic bone marrow transplantation with anti-CD3/TCR monoclonal antibodies. Hebart H; Ehninger G; Schmidt H; Berner B; Reuss-Borst M; Waller HD; Müller CA; Einsele H Bone Marrow Transplant; 1995 Jun; 15(6):891-4. PubMed ID: 7581087 [TBL] [Abstract][Full Text] [Related]